Sort
40,608 grants matching “prostate cancer”
Pharmcogenomic dissection of mTOR translational targets in prostate cancer
$386,369Davide Ruggero · University Of California, San Francisco · R01 · FY2011 · CA
Signaling Network Dynamics in Metastatic Prostate Cancer
$386,344David S. Lawrence · Univ Of North Carolina Chapel Hill · R01 · FY2013 · CA
Understanding Resistance to Next Generation Antiandrogens
$386,325Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Metabolic Imaging of the Prostate Using 3D MRSI
$386,311University Of California San Francisco · R01 · FY2005 · CA
Vitamin D Analogs for Chemoprevention of Prostate CAncer
$386,285Barbara A Foster · Roswell Park Cancer Institute Corp · R01 · FY2009 · CA
Ligand-mediated, vehicle-free delivery of small RNAs
$386,276Andrea L Kasinski · Purdue University · R01 · FY2023 · CA
Pure Flavonolignans from S. marianum in Prostate Cancer
$386,258Nicholas Hunter Oberlies · Research Triangle Institute · R01 · FY2008 · CA
Protection Against Gram-Negative Sepsis Conferred by Lipid A-Based Structural Variants
$386,250Robert K Ernst · University Of Maryland Baltimore · R01 · FY2019 · AI
Protection Against Gram-Negative Sepsis Conferred by Lipid A-Based Structural Variants
$386,250Robert K Ernst · University Of Maryland Baltimore · R01 · FY2018 · AI
Howard University Research Center for Minority Health and Health Disparities
$386,250William M Southerland · Howard University · U54 · FY2020 · MD
Protection Against Gram-Negative Sepsis Conferred by Lipid A-Based Structural Variants
$386,250Robert K Ernst · University Of Maryland Baltimore · R01 · FY2017 · AI
Prostatectomy vs watchful waiting - a randomized trial.
$386,237Gunnar Steineck · Karolinska Institute · R01 · FY2010 · CA
(PQA1) The antipsychotic thioridazine protects against medulloblastoma (MB): volu
$386,223Lily Y Jan · University Of California, San Francisco · R01 · FY2014 · CA
Targeted tumoricidal bacteria
$386,199Ming Zhao · Anticancer, Inc. · R44 · FY2011 · CA
Controlled Release of Macromolecules
$386,153Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2011 · EB
Development of biophysical approaches to investigate high-resolution structure and dynamics of membrane proteins
$386,143Ayyalusamy Ramamoorthy · University Of Michigan At Ann Arbor · R35 · FY2021 · GM
TRANSGENIC MOUSE MODELS FOR STUDYING PROSTATE/GU DISEASE
$386,125Washington University · R01 · FY2000 · DK
Functional characterization of prostate cancer risk loci by high throughput sequencing
$386,114Liang Wang · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2020 · CA
Pragmatic randomized trial of polygenic risk scoring for common diseases in primary care
$386,100Jason L Vassy · Harvard Medical School · R35 · FY2020 · HG
Pragmatic randomized trial of polygenic risk scoring for common diseases in primary care
$386,100Jason L Vassy · Harvard Medical School · R35 · FY2021 · HG
Pragmatic randomized trial of polygenic risk scoring for common diseases in primary care
$386,100Jason L Vassy · Harvard Medical School · R35 · FY2019 · HG
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
$386,069Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2010 · CA
Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers
$386,067Sigrid Carlsson · Sloan-Kettering Inst Can Research · U01 · FY2023 · CA
Immune activation by necroptotic cell death
$386,054Andrew Atwell Oberst · University Of Washington · R01 · FY2019 · CA
Ligand-mediated, vehicle-free delivery of small RNAs
$386,024Andrea L Kasinski · Purdue University · R01 · FY2025 · CA